9 岁男孩接受 cobimetinib 治疗后出现进行性结节性组织细胞增生症。
Progressive nodular histiocytosis in a 9-year-old boy treated with cobimetinib.
机构信息
Department of Dermatology, Hospital Nacional de Pediatría "Prof. Dr. Juan P. Garrahan", Buenos Aires, Argentina.
Department of Hemato-Oncology, Hospital Nacional de Pediatría "Prof. Dr. Juan P. Garrahan", Buenos Aires, Argentina.
出版信息
Pediatr Dermatol. 2022 Jan;39(1):115-118. doi: 10.1111/pde.14887. Epub 2021 Dec 21.
Abstract
Progressive nodular histiocytosis is a rare variant of non-Langerhans cell histiocytosis that affects the skin and mucous membranes and displays a progressive clinical course and poor response to treatment. We describe a case of severe progressive nodular histiocytosis harboring a KRAS p.G12S mutation in a 9-year-old boy, refractory to chemotherapy, who was successfully treated with the MEK inhibitor cobimetinib. This is the first report of the use of MEK inhibition for this histiocytosis subtype in a pediatric patient.
摘要
进行性结节性组织细胞增生症是一种罕见的非朗格汉斯细胞组织细胞增生症变异型，影响皮肤和黏膜，表现为进行性临床病程和对治疗反应不佳。我们描述了一例 9 岁男孩患有严重进行性结节性组织细胞增生症，该患者携带有 KRAS p.G12S 突变，对化疗耐药，使用 MEK 抑制剂 cobimetinib 成功治疗。这是首例报道在儿科患者中使用 MEK 抑制治疗这种组织细胞增生症亚型的病例。
相似文献
1
Progressive nodular histiocytosis in a 9-year-old boy treated with cobimetinib.9 岁男孩接受 cobimetinib 治疗后出现进行性结节性组织细胞增生症。
Pediatr Dermatol. 2022 Jan;39(1):115-118. doi: 10.1111/pde.14887. Epub 2021 Dec 21.
2
Treatment of congenital Langerhans cell histiocytosis with cobimetinib.采用考比替尼治疗先天性朗格汉斯细胞组织细胞增生症。
Pediatr Dermatol. 2024 May-Jun;41(3):515-517. doi: 10.1111/pde.15512. Epub 2024 Feb 22.
3
Multiple arterial thrombosis and pericarditis revealing histiocytosis successfully treated with MEK-inhibitor cobimetinib.多发性动脉血栓形成和心包炎揭示组织细胞增多症，用MEK抑制剂考比替尼成功治疗。
Clin Exp Rheumatol. 2020 Jan-Feb;38(1):173-174. Epub 2019 Jul 22.
4
Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases.两例低剂量考比替尼治疗脑组织细胞增生症的报告
Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200233. doi: 10.1212/NXI.0000000000200233. Epub 2024 Apr 8.
5
Progressive nodular histiocytosis with dramatic response to cobimetinib.进行性结节性组织细胞增多症对考比替尼有显著反应。
JAAD Case Rep. 2022 Feb 2;22:110-113. doi: 10.1016/j.jdcr.2022.01.017. eCollection 2022 Apr.
6
[Erdheim-Chester disease: a rare histiocytosis with outstanding response to cobimetinib.].[ Erdheim-Chester病：一种对考比替尼有显著反应的罕见组织细胞增多症。]
Rev Fac Cien Med Univ Nac Cordoba. 2021 Dec 28;78(4):398-401. doi: 10.31053/1853.0605.v78.n4.30852.
7
An unusual case of progressive nodular histiocytosis.一例罕见的进行性结节性组织细胞增多症病例。
Int J Dermatol. 2022 Jan;61(1):e38-e40. doi: 10.1111/ijd.15886. Epub 2021 Sep 2.
8
[Treatment-refractory progressive nodular histiocytosis].[治疗难治性进行性结节性组织细胞增多症]
Hautarzt. 2020 Jul;71(Suppl 1):2-5. doi: 10.1007/s00105-020-04646-8.
9
[Progressive nodular histiocytosis--rare variant of cutaneous non-Langerhans cell histiocytosis].[进行性结节性组织细胞增多症——皮肤非朗格汉斯细胞组织细胞增多症的罕见变异型]
J Dtsch Dermatol Ges. 2006 Mar;4(3):236-8. doi: 10.1111/j.1610-0387.2006.05907.x.
10
Choroidal involvement in Rosai-Dorfman disease successfully treated with cobimetinib.罗氏病伴发的脉络膜累及经考比替尼治疗后成功缓解。
Indian J Ophthalmol. 2020 Sep;68(9):2051-2053. doi: 10.4103/ijo.IJO_1359_20.
引用本文的文献
1
Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: a longitudinal registry-based analysis.骨硬化性脂膜炎的症状、未满足的需求及生活质量：一项基于纵向注册研究的分析
Blood Adv. 2025 Sep 9;9(17):4415-4424. doi: 10.1182/bloodadvances.2024015659.
2
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.朗格汉斯细胞组织细胞增生症和组织细胞疾病的治疗：聚焦于 MAPK 通路抑制剂。
Paediatr Drugs. 2023 Jul;25(4):399-409. doi: 10.1007/s40272-023-00569-8. Epub 2023 May 19.
3
Treatment of progressive nodular histiocytosis: a case report.进行性结节性组织细胞增多症的治疗：一例报告
Ann Transl Med. 2022 Oct;10(20):1143. doi: 10.21037/atm-22-4987.
本文引用的文献
1
The various clinical spectra of juvenile xanthogranuloma: imaging for two case reports and review of the literature.幼年黄色肉芽肿的各种临床谱：两例病例报告的影像学表现并文献复习。
BMC Pediatr. 2019 Apr 24;19(1):128. doi: 10.1186/s12887-019-1490-y.
2
Efficacy of MEK inhibition in patients with histiocytic neoplasms.MEK 抑制在组织细胞肿瘤患者中的疗效。
Nature. 2019 Mar;567(7749):521-524. doi: 10.1038/s41586-019-1012-y. Epub 2019 Mar 13.
3
Progressive Nodular Histiocytosis with Large Nodules and a Bulky Mass.伴有大结节和巨大肿块的进行性结节性组织细胞增多症
Acta Derm Venereol. 2019 May 1;99(6):610-611. doi: 10.2340/00015555-3045.
4
Progressive nodular histiocytosis improved by methotrexate.甲氨蝶呤使进行性结节性组织细胞增多症病情改善。
Eur J Dermatol. 2017 Dec 1;27(6):661-663. doi: 10.1684/ejd.2017.3115.
5
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.巨噬细胞-树突状细胞谱系组织细胞增多症和肿瘤的修订分类
Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10.
6
Progressive Nodular Histiocytosis Associated with Eale's Disease.与伊尔斯病相关的进行性结节性组织细胞增多症
Indian J Dermatol. 2015 Jul-Aug;60(4):388-90. doi: 10.4103/0019-5154.160492.
7
Progressive nodular histiocytosis with normal karyotypic analysis.核型分析正常的进行性结节性组织细胞增多症
Dermatol Online J. 2013 Jun 15;19(6):18577.
8
Progressive nodular histiocytosis: a case report and literature review.进行性结节性组织细胞增多症：一例报告及文献复习
Int J Dermatol. 2011 Dec;50(12):1546-51. doi: 10.1111/j.1365-4632.2011.04904.x.
9
Progressive nodular histiocytosis.进行性结节性组织细胞增多症
J Dermatol. 2010 Dec;37(12):1071-3. doi: 10.1111/j.1346-8138.2010.00943.x. Epub 2010 Sep 29.
10
Progressive nodular histiocytosis: a case report with literature review, and discussion of differential diagnosis and classification.进行性结节性组织细胞增多症：一例报告并文献复习，兼论鉴别诊断与分类
J Cutan Pathol. 2009 Dec;36(12):1286-92. doi: 10.1111/j.1600-0560.2009.01454.x.
Zotero 插件